HSTO News and Press, Histogen Inc. From 03/09/23

2023-03-09 16:59:55 ET Histogen press release ( NASDAQ: HSTO ): FY GAAP EPS of -$3.46. Revenue of $3.77M (+266.0% Y/Y) misses by $0.35M . For further details see: Histogen GAAP EPS of -$3.46, revenue of $3.77M misses by $0.35M

SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore i...

SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing its pan-caspase and caspase selective inhibitors as treatments for infectious and inflammatory diseases and has a pipeline of restorative therapeutics for orthope...

SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing its pan-caspase and caspase selective inhibitors as treatments for infectious and inflammatory diseases and has a pipeline of restorative therapeutics for orthope...

Histogen press release ( NASDAQ: HSTO ): Q3 GAAP EPS of -$1.01. Cash and cash equivalents - as of September 30, 2022, we had $14.6 million in cash and cash equivalents. Histogen believes that its existing cash and cash equivalents and cash inflow from operations will ...

SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics for orthopedic indications and pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammat...

3 Factors to Consider When Buying Biotech Penny Stocks Penny stocks in the biotech sector can be a great way to make money in the stock market. While these stocks are often overlooked by major investors, they can offer huge returns if you know what to look for. Here are three reasons wh...

Blue Water Vaccines ( BWV ) -30% . Eargo ( EAR ) -14% erasing yesterday's gain following FDA clearing over-the-counter hearing aid sales . Accelerate Diagnostics ( AXDX ) -13% on proposed public offering of common stock . Histogen ( HSTO ) ...

Shares of micro-cap clinical-stage therapeutics company Histogen ( NASDAQ: HSTO ) fell 8% to $1.95 in Friday afternoon trading, after the company reported a quarterly loss. The stock has been on a downward trend lately and, if today's losses hold, would post a sixth ...

Histogen press release ( NASDAQ: HSTO ): Q2 GAAP EPS of -$1.55. Cash and cash equivalents as of June 30, 2022 were $12.6M which excludes gross proceeds of approximately $5M from the private placement financing closed in July 2022. For further details see: Histoge...